Tokyo, Nov. 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063604) titled 'Changes in patient and caregiver burden after switching lecanemab from intravenous infusion to subcutaneous injection' on Nov. 12.
Study Type:
Observational
Primary Sponsor:
Institute - Morioka Oura Neurology clinic
Condition:
Condition - Mild cognitive impairment or mild dementia due to Alzheimer's disease.
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate within-patient changes in overall treatment burden from before switching to 8 weeks after starting subcutaneous lecanemab among patients who elect to switch from intravenous treatment in routine care....